EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells

Zhiwei Yuan, Taiyan Yu, Xu Wang, Kelin Meng, Tianlai Wang, Boyu Wang, Yu Xi, Congjian Wang, Chenxi Zeng, Shaojie Hu, Yitao Tian, Hui Xiong und 6 weitere

Pharmacological Research · 2025

DOI: 10.1016/j.phrs.2025.107643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2025. Verfasst von Zhiwei Yuan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, …. Hauptthemen laut MEDLINE: Glutamine, Interferon-gamma, Drug Resistance, Neoplasm, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutamine metabolism is emerging as a target for improving immunotherapy efficacy. However, the outcomes remain inconclusive. Given that the tumor-intrinsic response to interferon-γ (IFN-γ) is a key determinant of immunotherapy efficacy, we investigated whether and how glutamine deprivation in cancer cells affects their response to IFN-γ. By using human lung cancer cell lines, patient-derived tumor explants, and a syngeneic mouse model of lung cancer, we demonstrated that glutamine deprivation reduced the IFN-γ-driven response in cancer cells by promoting autophagy-dependent IFN-γ receptor (IFNGR1) degradation and rendering tumors resistant to anti-PD-1 or anti-PD-L1 therapy. Treatment with V9302, an inhibitor of the alanine-serine-cysteine transporter (ASCT2), enhanced the IFN-γ-driven response of cancer cells and increased the efficacy of PD-1 blockade therapy. Mechanistic analysis revealed that V9302 inhibited autophagy by impairing lysosomal activity independent of glutamine deprivation, likely because of its physiochemical properties, thereby preventing IFNGR1 degradation. Moreover, V9302 also increased Glut1 expression through the inhibition of lysosomal pathway-dependent degradation of Glut1 and consequently increased cancer cell glucose uptake, in turn retaining the levels of intracellular alpha-ketoglutarate (α-KG) and ATP, which are involved in maintaining IFN-γ signal transduction in cancer cells. In support of these findings, targeting lysosomal activity with chloroquine (CQ) also increased IFNGR1 expression and the IFN-γ-driven response in cancer cells. The administration of CQ increased the sensitivity of ASCT2-deficient tumors to anti-PD-L1 therapy. Glutamine deprivation per se leads to resistance to immunotherapy, whereas V9302 treatment results in increased immunotherapy efficacy through impaired lysosomal activity, which is independent of glutamine deprivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutamineInterferon-gammaDrug Resistance, NeoplasmLung NeoplasmsHumansAnimalsSignal TransductionCell Line, TumorAmino Acid Transport System ASCImmunotherapyMiceAutophagyLysosomesInterferon gamma ReceptorGlucose Transporter Type 1Receptors, InterferonImmune Checkpoint InhibitorsMice, Inbred C57BLMinor Histocompatibility Antigens

Stichwörter der Autor:innen

AutophagyGlutamine metabolismIFN-γ signalingImmunotherapyNon-small cell lung cancerV9302

Substanzen

GlutamineInterferon-gammaAmino Acid Transport System ASCInterferon gamma ReceptorGlucose Transporter Type 1Receptors, InterferonSLC1A5 protein, humanImmune Checkpoint InhibitorsMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: fuxn2006@aliyun.com.
  • Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: lqli@tjh.tjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yuan, Z., Yu, T., Wang, X., Meng, K., Wang, T., Wang, B., Xi, Y., Wang, C., Zeng, C., Hu, S., Tian, Y., Xiong, H., Wang, Q., Zou, W., Wang, X., Gao, Y., Fu, X., & Li, L. (2025). Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells. Pharmacological Research. https://doi.org/10.1016/j.phrs.2025.107643

Vancouver

Yuan Z, Yu T, Wang X, Meng K, Wang T, Wang B, et al. Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells. Pharmacological Research. 2025. doi:10.1016/j.phrs.2025.107643

BibTeX
@article{Yuan2025,
  author = {Yuan, Zhiwei and Yu, Taiyan and Wang, Xu and Meng, Kelin and Wang, Tianlai and Wang, Boyu and Xi, Yu and Wang, Congjian and Zeng, Chenxi and Hu, Shaojie and Tian, Yitao and Xiong, Hui and Wang, Qi and Zou, Wenbin and Wang, Xue and Gao, Yi and Fu, Xiangning and Li, Lequn},
  title = {Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells},
  journal = {Pharmacological Research},
  year = {2025},
  doi = {10.1016/j.phrs.2025.107643}
}
Kostenlos starten →